Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Piramal Enterprises appoints new executive director

This article was originally published in Scrip

Executive Summary

Indian company Piramal Enterprises, parent company of Piramal Healthcare, has appointed Murari Rajan executive director with responsibility for mergers, acquisitions and corporate development. Mr Rajan joins Piramal with over 15 years' experience in the financial services industry; prior to the appointment he was a consultant at Egon Zehnder International in the Financial Services Practice in New York. Mr Rajan will lead the strategy and M&A efforts for both Piramal Healthcare and Piramal Glass Limited, as well as hold a position on the investment committee of IndiaReit and India Ventures.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC030578

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel